Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > pdx

PDX (10-Propargyl-10-Deazaaminopterin) : Allos Therapeutics : Antifolate compound

PDX (Allos Therapeutics)
Discusses encouraging results of a phase 2 study of PDX in patients with stage IIIB or IV NSCLC. [2003]

Phase 1 Results of PDX in Patients with Advanced NSCLC (Allos Therapeutics)
Press release announces results of a phase 1 clinical trial of 10-Propargyl-10-Deazaaminopterin (PDX) plus docetaxel or paclitaxel in patients with advanced cancer. Results indicate that the study doses were active and well-tolerated. A phase 2 trial in patients with NSCLC is planned. [11/03]

PDX - Recent MEDLINE Abstracts


 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 18-Feb-2009
Karen Parles, MLS Editor